RAMM Pharma (XCNQ:RAMM) Total Inventories: C$0.88 Mil (As of Jan. 2026)

What is RAMM Pharma Total Inventories?

RAMM Pharma XCNQ:RAMM Total Inventories is C$0.88 Mil as of Jan. 2026. The stock has 4 warning signs investors should review.

RAMM Pharma's total inventories for the quarter that ended in Jan. 2026 was C$0.88 Mil. RAMM Pharma's average total inventories from the quarter that ended in Oct. 2025 to the quarter that ended in Jan. 2026 was C$0.90 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. RAMM Pharma's Net-Net Working Capital per share for the quarter that ended in Jan. 2026 was C$-0.02.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. RAMM Pharma's Days Inventory for the three months ended in Jan. 2026 was 1,068.34.

Inventory Turnover measures how fast the company turns over its inventory within a year. RAMM Pharma's Inventory Turnover for the quarter that ended in Jan. 2026 was 0.09.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. RAMM Pharma's Inventory-to-Revenue for the quarter that ended in Jan. 2026 was 4.23.

RAMM Pharma (XCNQ:RAMM) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

RAMM Pharma's Net-Net Working Capital Per Share for the quarter that ended in Jan. 2026 is

	Net-Net Working Capital Per Share (Q: Jan. 2026 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.985	+	0.75 * 0.112	+	0.5 * 0.876	-	3.558
-	0	-	0)	/	119.389
=	-0.02

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

RAMM Pharma's Days Inventory for the three months ended in Jan. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jan. 2026 )	/	Cost of Goods Sold (Q: Jan. 2026 )	*	Days in Period
	=	0.9015	/	0.077	*	365 / 4
	=	1,068.34

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

RAMM Pharma's Inventory Turnover for the quarter that ended in Jan. 2026 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jan. 2026 )	/	Average Total Inventories (Q: Jan. 2026 )
	=	0.077	/	0.9015
	=	0.09

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

RAMM Pharma's Inventory to Revenue for the quarter that ended in Jan. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Jan. 2026 )	/	Revenue (Q: Jan. 2026 )
	=	0.9015	/	0.213
	=	4.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

RAMM Pharma Total Inventories Related Terms

RAMM Pharma Total Inventories Historical Data

* Premium members only.

The historical data trend for RAMM Pharma's Total Inventories can be seen below:

RAMM Pharma Total Inventories Chart

RAMM Pharma Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Oct25

Total Inventories

Get a 7-Day Free Trial

3.05

4.02

3.14

2.54

0.93

RAMM Pharma Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25	Jan26
Total Inventories	Get a 7-Day Free Trial															2.02	1.95	1.59	0.93	0.88

RAMM Pharma Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →

What does a Total Inventories of C$0.88 Mil mean?

RAMM Pharma (XCNQ:RAMM) has a Total Inventories of C$0.88 Mil as of Jan. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for RAMM Pharma and its competitors.

Is RAMM Pharma's Total Inventories too high?

RAMM Pharma's current Total Inventories is C$0.88 Mil.

How does RAMM Pharma's Total Inventories compare to ZTS and UTHR?

RAMM Pharma's Total Inventories of C$0.88 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Inventories for a Drug Manufacturers company?

A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Inventories mean?

A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for RAMM Pharma and its competitors. RAMM Pharma's current Total Inventories is C$0.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is RAMM Pharma stock overvalued right now?

Based on GuruFocus' analysis, RAMM Pharma (XCNQ:RAMM) is currently considered Fairly Valued. The stock's GF Value™ is C$0.01, compared to a current price of C$0.01 — trading right at its estimated fair value. The current Total Inventories is C$0.88 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Inventories calculated?

Total Inventories is calculated from a company's financial statements. For RAMM Pharma (XCNQ:RAMM), the current Total Inventories is C$0.88 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RAMM Pharma Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XCNQ:CRCC XCNQ:PHRX XCNQ:VENI XCNQ:STKT XCNQ:CVGR XCNQ:TGIF TSXV:GENX XCNQ:CPTR XCNQ:PLCN XCNQ:JOLT XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Address 82 Richmond Street E, Toronto, ON, CAN, M5C 1P1

Website https://www.wearerammpharma.com

RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.